Todd Belanger

820 total citations
9 papers, 99 citations indexed

About

Todd Belanger is a scholar working on Epidemiology, Oncology and Immunology. According to data from OpenAlex, Todd Belanger has authored 9 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Todd Belanger's work include Pneumonia and Respiratory Infections (5 papers), Influenza Virus Research Studies (3 papers) and Respiratory viral infections research (2 papers). Todd Belanger is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Influenza Virus Research Studies (3 papers) and Respiratory viral infections research (2 papers). Todd Belanger collaborates with scholars based in United States, Germany and Japan. Todd Belanger's co-authors include Jane L. Liesveld, Nicki Panoskaltsis, Camille N. Abboud, Camille N. Abboud, Karen Rosell, Daniel A. Scott, William C. Gruber, Wendy Watson, Kari Yacisin and Yahong Peng and has published in prestigious journals such as Vaccine, Human Vaccines & Immunotherapeutics and Blood Cells Molecules and Diseases.

In The Last Decade

Todd Belanger

9 papers receiving 97 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Todd Belanger United States 6 40 39 23 16 14 9 99
Hama Diallo Mali 5 55 1.4× 51 1.3× 42 1.8× 13 0.8× 11 0.8× 5 156
Aloysius Ssemaganda Uganda 4 30 0.8× 65 1.7× 7 0.3× 6 0.4× 3 0.2× 5 107
Melissa Ng Singapore 6 23 0.6× 64 1.6× 25 1.1× 23 1.4× 4 0.3× 10 149
Alberto San Francisco Ramos United Kingdom 4 16 0.4× 10 0.3× 11 0.5× 31 1.9× 6 0.4× 9 78
Olga Rivera‐Ballesteros Sweden 5 9 0.2× 36 0.9× 13 0.6× 18 1.1× 4 0.3× 6 82
Pamela Aranda Lopez Germany 8 25 0.6× 94 2.4× 18 0.8× 20 1.3× 9 0.6× 15 131
Dennis C. Copertino United States 6 19 0.5× 57 1.5× 12 0.5× 18 1.1× 15 1.1× 8 123
Yan Wen China 5 38 0.9× 28 0.7× 15 0.7× 29 1.8× 16 1.1× 23 114
Cristina Cifaldi Italy 8 26 0.7× 81 2.1× 14 0.6× 25 1.6× 13 0.9× 18 122
Angela Grainger United Kingdom 8 41 1.0× 56 1.4× 8 0.3× 16 1.0× 5 0.4× 8 118

Countries citing papers authored by Todd Belanger

Since Specialization
Citations

This map shows the geographic impact of Todd Belanger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd Belanger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd Belanger more than expected).

Fields of papers citing papers by Todd Belanger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd Belanger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd Belanger. The network helps show where Todd Belanger may publish in the future.

Co-authorship network of co-authors of Todd Belanger

This figure shows the co-authorship network connecting the top 25 collaborators of Todd Belanger. A scholar is included among the top collaborators of Todd Belanger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd Belanger. Todd Belanger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Cannon, Kevin, José F. Cardona, Kari Yacisin, et al.. (2023). Safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine coadministered with quadrivalent influenza vaccine: A phase 3 randomized trial. Vaccine. 41(13). 2137–2146. 12 indexed citations
3.
Sabharwal, Charu, Vani Sundaraiyer, Yahong Peng, et al.. (2022). Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease. Human Vaccines & Immunotherapeutics. 18(6). 2126253–2126253. 2 indexed citations
4.
Scully, Ingrid L., Mark Cutler, Todd Belanger, et al.. (2019). 1337. Development, Maintenance, and Application of Opsonophagocytic Assays to Measure Functional Antibody Responses to Support a 20 Valent Pneumococcal Conjugate Vaccine. Open Forum Infectious Diseases. 6(Supplement_2). S484–S484. 6 indexed citations
5.
Shiramoto, Masanari, Shin Irie, Christine Juergens, et al.. (2014). Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. Human Vaccines & Immunotherapeutics. 10(7). 1850–1858. 13 indexed citations
6.
Coppage, Myra, Todd Belanger, Maurice Zauderer, & Deepak M. Sahasrabudhe. (2006). In vitro generation of tumor specific T cells that recognize a shared antigen of AML: Molecular characterization of TCR genes. Leukemia Research. 31(2). 195–202. 2 indexed citations
7.
Panoskaltsis, Nicki, Todd Belanger, Jane L. Liesveld, & Camille N. Abboud. (2002). Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture. Leukemia Research. 26(2). 191–201. 25 indexed citations
8.
Liesveld, Jane L., et al.. (2001). Response of Human CD34 + Cells to CXC, CC, and CX 3 C Chemokines: Implications for Cell Migration and Activation. Journal of Hematotherapy & Stem Cell Research. 10(5). 643–655. 21 indexed citations
9.
Liesveld, Jane L., et al.. (2000). MIP-1α and TGF-β Production in CD34+ Progenitor–Stromal Cell Coculture Systems: Effects of Progenitor Isolation Method and Cell–Cell Contact. Blood Cells Molecules and Diseases. 26(4). 261–275. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hama Diallo Breakdown of academic impact, for papers by Aloysius Ssemaganda Breakdown of academic impact, for papers by Melissa Ng Breakdown of academic impact, for papers by Alberto San Francisco Ramos Breakdown of academic impact, for papers by Olga Rivera‐Ballesteros Breakdown of academic impact, for papers by Pamela Aranda Lopez Breakdown of academic impact, for papers by Dennis C. Copertino Breakdown of academic impact, for papers by Yan Wen Breakdown of academic impact, for papers by Cristina Cifaldi Breakdown of academic impact, for papers by Angela Grainger
Rankless by CCL
2026